Long-term effects of ATG therapy on lymphocyte subsets.
Martins
L
L
Nephrology and Transplant Department, Hospital de Santo António, Porto, Portugal.
Ventura
A
A
Dias
L
L
Henriques
A
A
Sarmento
A
A
Guimarães
S
S
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D017252:CD3 Complex / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012016:Reference Values; D013997:Time Factors
D000961:Antilymphocyte Serum; D017252:CD3 Complex; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008775:Methylprednisolone